发明名称 |
Pharmaceutical compositions providing enhanced drug concentrations |
摘要 |
A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer. |
申请公布号 |
US9457095(B2) |
申请公布日期 |
2016.10.04 |
申请号 |
US201514659271 |
申请日期 |
2015.03.16 |
申请人 |
Bend Research, Inc. |
发明人 |
Curatolo William J.;Shanker Ravi M.;Babcock Walter C.;Friesen Dwayne T.;Nightingale James A. S.;Lorenz Douglas A. |
分类号 |
A61K47/38;A61K9/14;A61K9/16;A61K31/135;A61K31/4375;A61K31/4178;A61K31/496;A61K31/517;A61K31/404 |
主分类号 |
A61K47/38 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. A composition comprising:
(a) a drug in a pharmaceutically acceptable form that is a crystalline highly soluble salt form other than the crystalline hydrochloride salt, wherein the crystalline highly soluble salt form has an aqueous solubility at least 1.25-fold the aqueous solubility of the more soluble of the crystalline free base and the crystalline hydrochloride salt forms of the drug; and (b) a concentration-enhancing polymer,wherein said drug alone has an aqueous solubility of up to 2 mg/mL at pH 1 to 8; and said composition is not a molecular dispersion. |
地址 |
Bend OR US |